This is a study to compare the effectiveness of a drug called Corlux (mifepristone) to a placebo in adults who suffer from psychotic symptoms associated with major depression. This national study is currently recruiting adults ages 22 to 75 years old who have major depressive disorder with psychotic features.
Read moreMany of you have talked about how your spiritual faith has helped you through some emotionally turbulent times. Others talk about having a... Read more »
In May 2009 I fell into a depressive pit that lasted a good 10 months. During that time I spent whole days away from my computer - where,... Read more »
Even after I was diagnosed with bipolar disorder, I often doubted the diagnosis. The reason was that my "up" periods were so rare, my... Read more »
Did you know.... At least 80% of people suffering from depression experience insomnia. Insomnia may precede depression by about five... Read more »
This is a study to assess the safety, tolerability, and effectiveness of Geodon (ziprasidone) as a stand-alone treatment for people with major... Read more »
This is a study to assess the safety and effectiveness of Valdoxan in patients with major depressive disorder. This national study is currently... Read more »
This is a study to assess the safety and effectiveness of a new medication (PRX-00023) in patients with major depressive disorder. This national... Read more »
This is a study to determine if the addition of aripiprazole to Effexor or another currently approved antidepressant will improve symptoms of major... Read more »
This is a study to determine the effectiveness of Lexapro (escitalopram) in teenagers ages 12 to 17 who suffer from major depressive disorder. This... Read more »